您现在位置:健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告
健康网讯:
Market Research Report on Cerebral Function Improving Drugs 价格: 2200美元 Summary 1 Overview of brain dysfunction and the epidemiology 1.1 Mental disorders of old people 1.2 Senile dementia and its subcategories 1.3 New outcome of epidemiology 1.4 Market potential 1.5 Theoretical market capacity 2 Categories of Cerebral Function Improving Drugs and their action mechanisms respectively 2.1 Overview of popular categories of drugs 2.2 Anticholinesterase drugs (AchEI) 2.3 Kind of pyrroliidne 2.4 Calcium ion inhibitors 2.5 Neurotrophins 2.6 Kind of alkaloids for activation of energy 3 Market analysis of Cerebral Function Improving Drugs 3.1 Sales trend in sample hospitals 3.2 Market shares of different categories 4 Market analysis of key breeds (including sales value, key enterprises and their maket shares respectively etc) 4.1 Donepezil 4.2 Rivastigmine 4.3 Galantamine 4.4 Piracetam 4.5 Aniracetam 4.6 Vinpocetine 4.7 Nicergoline 4.8 Dihydroergotoxine 4.9 Huperaine A 4.10 Ginkgo Leaves Agent 4.11 Brain Protein Hydrolysate 4.12 Citicoline
|